Clinical Trial Update: The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of a phosphatidylserine-omega-3 supplement in children with attention-deficit/hyperactivity disorder has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Phosphatidylserine-Omega-3 (phosphatidylserine omega-3 fatty acid combination)

Snippet

Sponsor: Enzymotec | Conditions: Attention Deficit/Hyperactivity Disorder (ADHD) | Phase 2 | Status: COMPLETED | Results posted: 2010-02-26